Culture

Variety: Spice of life for bumble bees

image: The research team put honey bee and bumble bee colonies next to an experimental field.

Image: 
Svenja Bänsch, University of Göttingen

The yield and quality of many crops benefit from pollination, but it isn't just honey bees that do this work: bumble bees also have a role. However, placing honey bee or bumble bee colonies next to the field does not guarantee that they will visit the desired plants since there may be other plant species flowering at the same time that prove more attractive. A team from the University of Göttingen, together with researchers from the University of Applied Sciences Mittweida and the Julius Kühn Institute, used innovative molecular biological methods and traditional microscopy to investigate the pollen collecting behaviour of honey bees and bumble bees in agricultural landscapes. They show that bumble bees take much more pollen from dif-ferent plant species than honey bees to satisfy their need for protein. Furthermore, less pollen from the target - in this case strawberry plants - is collected when there are fields of flowering oilseed rape in the surrounding landscape. The results have been published in the journal Molecular Ecology.

The researchers placed honey bee and bumble bee colonies next to strawberry fields in the Göttingen and Kassel region and collected pollen from returning honey bees and bumble bees. The bees collect the pro-tein-rich pollen mainly for feeding their offspring. The pollen DNA was investigated working closely with the Division of Molecular Biology of Livestock and molecular Diagnostics at the University of Göttingen, and the Department of Biochemistry/Molecular Biology of the Mittweida University of Applied Sciences. "DNA analysis tells us which plant species the bees have visited and how diverse their foraging behaviour is. To do this, we sequenced the DNA of the pollen and compared the sequences using a database of regional plant species," says Dr Svenja Bänsch, post-doctoral researcher in Functional Agrobiodiversity at the Uni-versity of Göttingen.

"Our study shows that honey bees and bumble bees use very different plants to source their pollen in the landscape. In particular, the wide range of bumble bee nutrition, which they find mainly in flower-rich habi-tats, should be taken into account when taking steps to improve nature conservation. Both honey bees and bumble bees, whose colonies can be purchased or rented, are suitable pollinators in strawberry cultivation. However, naturally occurring wild bees should be encouraged as a priority," concludes Professor Catrin Westphal, Head of Functional Agrobiodiversity at the University of Göttingen.

Credit: 
University of Göttingen

Stanford University study: 12 Tel Aviv University researchers among top 50 in the world

image: Professor Dan Peer, Vice President for Research, Tel Aviv University

Image: 
American Friends of Tel Aviv University (AFTAU)

A new study from Stanford University identified 12 Tel Aviv University (TAU) researchers among the world's top 50 researchers in their fields. 333 TAU faculty members were also ranked among the top 2% of researchers in their respective disciplines based on publications, citations, and impact. 155 of them are included in the top 1%, and 74 in the top 0.5%.

The study appeared in PLOS Biology on October 16, 2020.

TAU's Vice President for Research, Professor Dan Peer, himself ranked among the top 0.4% in the world in nanotechnology, says, "This is a cause for real national pride. TAU is known for its academic excellence and recognized as a leading interdisciplinary university. It is a great honor for us that 333 of our researchers rank among the top 2% of the world's best researchers."

Professor Itzhak Gilboa from the Berglas School of Economics is ranked sixth in the world in Theoretical Economics, and his colleague Professor Emeritus David Schmeidler from the School of Mathematical Sciences is 12th in the world in the same discipline. Professor Jiska Cohen-Mansfield from the Sackler Faculty of Medicine is ranked 12th in the world in the field of Geriatrics. Three faculty members from the Fleischman Faculty of Engineering also rank high in their fields of research: Professor Emilia Fridman (at #26), Professor Emeritus Gedeon Dagan (#29), and Professor Boris Malomed (#29).

Professor Emeritus Micha Sharir from the Blavatnik School of Computer Science is ranked 35th and Professor Arie Levant from the School of Mathematical Sciences is ranked 36th. Four faculty members from the Entin Faculty of Humanities also appear on the list: Professor Emeritus Rachel Giora from the Department of Linguistics (ranked 40th in the world), Professor Israel Finkelstein from the Department of Archaeology (#44), Professor Emeritus Benjamin Isaac from the Department of Classics (#45), and Professor Emeritus Elana Shohamy from the Constantiner School of Education (#47).

Credit: 
American Friends of Tel Aviv University

Young people regarded COVID-19 as a threat to the older generation but not to themselves

image: During the early stages of the COVID-19 outbreak, young Singaporeans understood the infectious disease to be risky for their parents and older relatives, but not themselves, a Nanyang Technological University, Singapore (NTU Singapore) study has found.

Image: 
NTU Singapore

At the start of the pandemic, young Singaporeans regarded COVID-19 as a threat to the older generation but not to themselves, finds NTU Singapore study

During the early stages of the COVID-19 outbreak, young Singaporeans understood the infectious disease to be risky for their parents and older relatives, but not themselves, a Nanyang Technological University, Singapore (NTU Singapore) study has found.

Young Singaporeans were more concerned about the dangers of fake news surrounding COVID-19 rather than the health threat posed by the disease and believed misinformation about the pandemic affected the older generation more than them.

The study led by NTU Singapore's Associate Professor Edson Tandoc Jr and researcher James Lee Chong Boi involved eight focus group discussions with 89 participants aged 21 to 27.

The discussions were held in early February, two months after the first COVID-19 case in the world was confirmed in China last year. Singapore saw its first case in January. At the start of the study, 24 cases here had been confirmed, increasing to 74 by the time the last focus group discussion was conducted. China's numbers were rising exponentially and South Korea had started reporting a steady rise in its number of cases.

Through the focus groups, the two authors from NTU's Wee Kim Wee School of Communication and Information (WKWSCI) found that rather than actively seeking information about COVID-19, many young adults got their news about the virus from social media platforms and messaging platforms such as WhatsApp.

This in turn shaped their view that the virus was risky for older generations but not for themselves, which in turn shaped their behavioural response to the outbreak, such as not wearing face masks, which was not mandated in the early stages of the outbreak.

Assoc Prof Tandoc, who led the study, said: "Studying initial public reaction towards a health crisis like the COVID-19 pandemic could guide practitioners and social policy makers on how to handle the outbreak in the long term. An important consideration from these findings is how to make young people who think they are not prone to COVID-19 to be still engaging in proactive behaviours against the virus. This is even more important during the initial phase of the pandemic, where credible information about the new virus was scarce.

"The results also document how making sense of what is happening in the early stages of a health crisis can go beyond the disease itself and focus more on social order and information quality, which can also shape behaviours. This process of sensemaking, shaped young Singaporeans' initial view that they are not vulnerable to the virus. This also might explain why some young people, such as those reported in other countries, continued to engage in risky behaviour, like going to the beach or partying, during the pandemic."

The study was published in the peer-reviewed academic journal New Media & Society in October.

When misinformation becomes viral

Like in other countries, the COVID-19 outbreak in Singapore was accompanied by an 'infodemic' - a wave of fake news about the pandemic - from messages claiming malls and MRT stations were closed due to suspected cases, to various home remedies to protect oneself from the virus, such as drinking sesame oil. Such misinformation could undermine global response to the crisis and jeopardise health warnings and precautionary measures employed by health officials in containing the disease, said the researchers.

Perceiving the virus as not a big threat to their age group, the participants said that they were more focused on combating the spread of misinformation. The young adults felt the COVID-19 falsehoods affected their parents and older relatives more than themselves. Many of these instances of information sharing were facilitated by messaging apps, such as WhatsApp, the most popular messaging app in Singapore.

One respondent cited generational differences as a factor. His generation would seek to verify a piece of new information, such as a list of 'COVID-19 hotspots' that would later be debunked as a falsehood, rather than to accept it without question. But his parents' generation would change their behaviour based solely on the information, taking a "just-in-case" approach instead.

Assoc Prof Tandoc said: "It was interesting to hear how participants felt the need to actively protect their parents and older relatives from misinformation about COVID-19. This contributed to how they made sense of the outbreak, understanding it more as an issue of social order that involves tackling misinformation so people would not panic, than as a health risk.

"Fighting misinformation is particularly crucial in a time like this, when information flows quickly through channels like social media and messaging apps, to protect not just ourselves but also others in the community. It is therefore important for us to keep an eye not only on the public's information behaviour, but also on the quality of information flowing through various channels - an effort that the work my colleagues and I are doing at WKWSCI seeks to contribute to."

Credit: 
Nanyang Technological University

Sixfold increase in risk

image: Women infected with HIV are six times more likely to develop cervical cancer. This is what Dr. Dominik Stelzle and Dr. Luana Tanaka found out as part of a study by the Center for Global Health at the Technical University of Munich.

Image: 
Andreas Heddergott / TUM

A research team at the Technical University of Munich (TUM) has quantified the effects of an infection with the Human Immunodeficiency Virus (HIV) on the development of cervical cancer. Their results show that the risk of developing cervical cancer is six times higher in women who are infected with HIV. Southern and Eastern Africa are particularly affected.

According to WHO statistics, cervical cancer is the fourth most common type of cancer for women. In 2018 an estimated 570,000 women worldwide were diagnosed with cervical carcinoma, with approximately 311,000 of these women dying.

On the other hand cervical cancer, usually caused by Human Papillomavirus (HPV), is also one of the most successfully preventable and treatable types of cancer, as long as it is detected at an early stage and treated effectively.

Cervical cancer is at the same time the most frequently detected cancer for women who live with HIV, since their immune systems are weakened by the HIV infection.

The TUM School of Medicine's Center for Global Health and the Chair of Epidemiology at the TUM Department of Sport and Health Sciences have now dedicated their efforts to this relevant topic in the publication "Estimates of the Global Burden of Cervical Cancer Associated with HIV", published in the renowned journal The Lancet Global Health.

Systematic review and meta-analysis of 24 studies

The lead authors Dr. Dominik Stelzle (Center for Global Health and Chair of Epidemiology) and Dr. Luana Tanaka (Chair of Epidemiology) conducted a systematic review as well as a meta-analysis of a total of 24 studies from the years 1981 to 2016, in which 236,127 women with HIV from four continents (Africa, North America, Asia and Europe) participated.

These studies covered a total of 2,138 cervical carcinoma cases. The results were linked with data from UNAIDS on worldwide HIV infection and with data on cervical carcinoma from the International Agency for Research on Cancer (IARC), the WHO's Cancer Research Center, and then evaluated.

"Until now there have only been estimates from countries with high net income levels," says Dr. Stelzle. "That's why we looked at the figures on global incidence of cervical carcinoma in connection with an HIV infection and included estimates for countries with low net incomes. In most parts of the world the numbers are under five percent. In some countries however we're talking about well over 40 percent of cases."

Risk is six times higher for women with HIV

The objective of the study was to calculate the share of women living with HIV among the number of women with cervical cancer. The authors found that 5.8 percent of all new cervical cancer cases worldwide in the year 2018 were diagnosed for women with an HIV infection. This is equivalent to 33,000 cases a year, 85 percent of which occurred in Sub-Saharan Africa.

Furthermore, based on their results the team was able to show that women with HIV have a sixfold higher risk of developing cervical cancer than women without HIV infection.

"The association between cervical carcinoma and HIV is plausible," says Prof. Andrea S. Winkler, co-director of the Center for Global Health. "Cervical carcinomas are usually caused by infections with Human papillomavirus (HPV), which are sexually transmitted just as HIV is. Based on our results it can be assumed that an infection with HIV represents a risk factor for an infection with HPV."

Southern and eastern Afrika most affected

The regions most strongly affected are southern and eastern Africa, where respectively 63.8 percent and 27.4 percent of cervical carcinomas were diagnosed in women with an HIV infection.

"With over 75 percent, Eswatini in southern Africa is the country with the highest share of women suffering from cervical cancer in connection with an HIV infection, followed by Lesotho with 69 percent, Botswana with 67 percent, South Africa with 64 percent and Zimbabwe with 52 percent," says Dr. Tanaka.

Based on the results, the TUM authors determined that women with an HIV infection have a significantly higher risk of developing cervical cancer. They also pointed out that this means that HPV vaccinations and early-stage cervical carcinoma screenings are of particular importance, especially in the African countries south of the Sahara.

"Although cervical cancer screenings already exist in Africa, until now they have been performed primarily on women with a higher socio-economic status who could afford the screening," says Prof. Stefanie Klug, who holds the Chair of Epidemiology at TU Munich. "The goal has to be to end this dependency on economic means and to succeed in introducing free HPV vaccination for girls and screening for adult women."

Credit: 
Technical University of Munich (TUM)

How nearby galaxies form their stars

image: Visualization of gas in and around a Milky-Way-like galaxy (center) in today's Universe as predicted by a cosmological simulation run by the author. Dense, atomic and molecular hydrogen typically forms an extended disk, here seen in bluish-purple at the center of the image. Stars (white) form throughout the gas disk. Additional star formation may take place in satellite galaxies, here seen at the top right and bottom left positions. Hot, low density gas (green and red hues) can be found at large distances, out to the edge of the dark matter halo surrounding the main galaxy (white circle). The image also shows a large number of dark matter substructures (purple) most of which are devoid of gas and stars.

Image: 
Robert Feldmann, UZH

Stars are born in dense clouds of molecular hydrogen gas that permeates interstellar space of most galaxies. While the physics of star formation is complex, recent years have seen substantial progress towards understanding how stars form in a galactic environment. What ultimately determines the level of star formation in galaxies, however, remains an open question.

In principle, two main factors influence the star formation activity: The amount of molecular gas that is present in galaxies and the timescale over which the gas reservoir is depleted by converting it into stars. While the gas mass of galaxies is regulated by a competition between gas inflows, outflows and consumption, the physics of the gas-to-star conversion is currently not well understood. Given its potentially critical role, many efforts have been undertaken to determine the gas depletion timescale observationally. However, these efforts resulted in conflicting findings partly because of the challenge in measuring gas masses reliably given current detection limits.

Typical star formation is linked to the overall gas reservoir

The present study from the Institute for Computational Science of the University of Zurich uses a new statistical method based on Bayesian modeling to properly account for galaxies with undetected amounts of molecular or atomic hydrogen to minimize observational bias. This new analysis reveals that, in typical star-forming galaxies, molecular and atomic hydrogen are converted into stars over approximately constant timescales of 1 and 10 billion years, respectively. However, extremely active galaxies ("starbursts") are found to have much shorter gas depletion timescales. "These findings suggest that star formation is indeed directly linked to the overall gas reservoir and thus set by the rate at which gas enters or leaves a galaxy," says Robert Feldmann, professor at the Center for Theoretical Astrophysics and Cosmology. In contrast, the dramatically higher star-formation activity of starbursts likely has a different physical origin, such as galaxy interactions or instabilities in galactic disks.

This analysis is based on observational data of nearby galaxies. Observations with the Atacama Large Millimeter/Submillimeter Array, the Square Kilometer Array and other observatories promise to probe the gas content of large numbers of galaxies across cosmic history. It will be paramount to continue the development of statistical and data-science methods to accurately extract the physical content from these new observations and to fully uncover the mysteries of star formation in galaxies.

Credit: 
University of Zurich

CRISPR helps researchers uncover how corals adjust to warming oceans

Baltimore, MD-- The CRISPR/Cas9 genome editing system can help scientists understand, and possibly improve, how corals respond to the environmental stresses of climate change. Work led by Phillip Cleves--who joined Carnegie's Department of Embryology this fall--details how the revolutionary, Nobel Prize-winning technology can be deployed to guide conservation efforts for fragile reef ecosystems.

Cleves' research team's findings were recently published in two papers in the Proceedings of the National Academy of Sciences.

Corals are marine invertebrates that build extensive calcium carbonate skeletons from which reefs are constructed. But this architecture is only possible because of a mutually beneficial relationship between the coral and various species of single-celled algae that live inside individual coral cells. These algae convert the Sun's energy into food using a process called photosynthesis and they share some of the nutrients they produce with their coral hosts--kind of like paying rent.

Coral reefs have great ecological, economic, and aesthetic value. Many communities depend on them for food and tourism. However, human activity is putting strain on coral reefs including warming oceans, pollution, and acidification and that affects this symbiotic relationship.

"In particular, increasing ocean temperatures can cause coral to lose their algae, a phenomenon called bleaching, because the coral takes on a ghostly white look in the absence of the algae's pigment," Cleves explained. "Without the nutrients provided by photosynthesis, the coral can die of starvation."

In 2018, Cleves headed up the team that demonstrated the first use of the CRISPR/Cas9 genome editing on coral. Now, his teams used CRISPR/Cas9 to identify a gene responsible for regulating coral's response to heat stress.

Working first in the anemone Aiptasia, one team--including Stanford University's Cory Krediet, Erik Lehnert, Masayuki Onishi, and John Pringle--identified a protein, called Heat Shock Factor 1 (HSF1), which activates many genes associated with the response to heat stress. Anemones are close coral relatives that have similar symbiotic relationships with photosynthetic algae, but they grow faster and are easier to study. These traits make Aiptasia a powerful model system to study coral biology in the lab.

Then another Cleves-led team--including Stanford University's Amanda Tinoco and John Pringle, Queensland University of Technology's Jacob Bradford and Dimitri Perrin, and Line Bay of the Australian Institute of Marine Science (AIMS)--used CRISPR/Cas9 to create mutations in the gene that encodes HSF1 in the coral Acropora millepora, demonstrating its importance for coping with a warming environment. Without a functioning HSF1 protein, the coral died rapidly when the surrounding water temperature increased.

"Understanding the genetic traits of heat tolerance of corals holds the key to understanding not only how corals will respond to climate change naturally but also balancing the benefits, opportunities and risks of novel management tools," said Bay, who is the AIMS principal research scientist and head of its Reef Recovery, Restoration and Adaptation team.

Added Cleves: "Our work further demonstrates how CRISPR/Cas9 can be used to elucidate aspects of coral physiology that can be used to guide conservation. This time we focused on one particular heat tolerance gene, but there are so many more mechanisms to reveal in order to truly understand coral biology and apply this knowledge to protecting these important communities."

Credit: 
Carnegie Institution for Science

Sex-specific Alzheimer's treatment could benefit males over females

image: Post-mortem brain tissue reveals the memory function in female and male Alzheimer's mice differed after they were treated with a drug that selectively blocks a receptor to regulate memory and learning.

Image: 
University of Ottawa

A University of Ottawa study has found a specific Alzheimer's treatment is effective in male and not female mice, providing a window into the biology of the disease and the effectiveness of targeted treatments.

The paper, 'AB oligomers induce pathophysiological mGluR5 signaling in Alzheimer's disease model mice in a sex-selective manner', published in Science Signaling Magazine highlights the mechanisms underlying Alzheimer's disease are fundamentally different between men and women in regards to one specific treatment.

The study was led by first author Dr. Khaled Abdelrahman alongside senior author Dr. Stephen Ferguson, both of the Faculty of Medicine's Department of Cellular and Molecular Medicine and the Brain and Mind Research Institute.

Dr. Abdelrahman shared some insights into the findings.

What exactly did you set to study?
"The research involved assessing the memory function in female and male Alzheimer's mice after they were treated with a drug that selectively blocks a receptor to regulate memory and learning. We then assessed the recovery of memory deficits after treatment and how it is different between sexes. We also examined whether the binding of a toxic Ab; peptide to this receptor is different between male and female mouse and human brain." (Note: An AB peptide is found in the brain of an Alzheimer's patient and is a hallmark of the disease.)

What did you find?
"We showed at least one promising Alzheimer's disease treatment was effective in reversing the disease in male mice but that it was unable to do so in female mice. This will have important implications for future drug discovery and clinical trials design for Alzheimer's disease."

How do these findings translate to humans?
"We utilized post-mortem brain tissue from male and female human donors to corroborate our findings. The benefit to humans is that these selective differences may be applicable to many drugs in the market or in clinical trial phases."

What kind of impact can this discovery have?
"We have to be careful when designing clinical trials in the future since many drug candidates have the opposite or different outcomes for both sexes; not all drugs that work for men will work with women, and vice-versa. It also changes how clinical trial data should be evaluated and segregated by sex. Importantly, it defines a previously unknown differences in the biophysical properties of an important receptor in the brain that regulates memory and learning."

What was your reaction to these findings?
"As a pharmacist, I have witnessed many patients in practice who struggle with Alzheimer's disease and ineffective treatments. This motivated me to make effort in understanding the mechanisms that lead to the disease for better therapeutic approaches to be undertaken."

Credit: 
University of Ottawa

Gene pathway linked to schizophrenia identified through stem cell engineering

image: These are neurons derived from induced pluripotent stem cells from a schizophrenia patient.

Image: 
(Photo by Laura Stertz, PhD/UTHealth)

Using human-induced pluripotent stem cells engineered from a single family's blood samples, a gene signaling pathway linked to a higher risk for developing schizophrenia was discovered by scientists at The University of Texas Health Science Center at Houston (UTHealth). The research was published in a recent issue of Neuropsychopharmacology.

The signaling pathway researchers pinpointed is called phosphoinositide 3-kinase/glycogen synthase kinase 3 (PI3K/GSK3). Among the differentially expressed genes along the pathway was one called serum-glucocorticoid kinase 1 (SGK1), an inhibitor of GSK3 beta, which has been associated with schizophrenia.

"We believe this has direct implications for the treatment of patients," said senior author Consuelo Walss-Bass, PhD, professor in the Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences at McGovern Medical School at UTHealth. "There is a new antipsychotic that just received approval from the Food and Drug Administration that directly targets the pathway we identified as dysregulated in neurons from the patients, and several other antipsychotics also target this pathway. This could help pinpoint who may respond better to treatments."

Researchers led by Walss-Bass and first author, postdoctoral research fellow Laura Stertz, PhD, used blood samples from adult members of a large family with multiple individuals affected by schizophrenia. Through human-induced pluripotent stem cell (hiPSC) technology, the blood cells were reprogrammed into stem cells, which were then directed to become brain neurons. Those neurons could be studied in a virtual biopsy and compared to neurons engineered from individuals who did not have schizophrenia, but came from the same family from a homogenous population in the Central Valley of Costa Rica.

"Mental health research has lagged behind because we don't know what is happening biologically. We are diagnosing people based on what they are telling us," Walss-Bass said. "Even postmortem, the brain tissue in mental health disorders looks perfectly fine. In Alzheimer's disease, you can see a difference compared to controls. But not in psychiatric disorders. Now by studying virtual brain biopsies, we can tell what is happening biologically."

Among the differentially expressed genes the researchers saw in the virtual biopsies were five that have previously been identified as schizophrenia candidate genes by genome-wide association studies.

Among the genes associated with the PI3K/GSK3 pathway was SGK1, which inhibits GSK3 activity. Those alterations are linked to whether a person has a higher risk of developing schizophrenia.

"We were able to find significant, meaningful differences with a small control group," Walss-Bass said. "Neurons of patients with schizophrenia had alterations in the signaling pathway. This research may help to understand how or why some antipsychotics targeting GSK3 work and also to develop other target-specific medications."

Walss-Bass said identifying patients with specific biological pathway markers could identify them as the best candidates for medications, creating the personal pharmacology that is needed to treat psychiatric disorders.

Credit: 
University of Texas Health Science Center at Houston

Citizens versus the internet: Confronting digital challenges with cognitive tools

Access to the Internet is essential for economic development, education, global communications, and countless other applications. For all its benefits, however, the Internet has a darker side. It has emerged as a conduit for spreading misinformation, stoking tensions, and promoting extremist ideologies. Yet there is hope.

In the latest issue of Psychological Science in the Public Interest, a team of researchers recommend ways that psychological and behavioral sciences can help decrease the negative consequences of Internet use. These recommendations emphasize helping people gain greater control over their digital environments.

"Psychological science can help to inform policy interventions in the digital world," said Anastasia Kozyreva, a researcher at the Center for Adaptive Rationality at the Max Planck Institute for Human Development in Germany and author on the paper. "It is crucial that psychological and behavioral sciences are employed to ensure users are not manipulated for financial gain and are empowered to detect and resist manipulation."

Specifically, psychological and cognitive sciences can complement interventions by other fields, such as law and ethics, which develops guidelines and regulations; education, which can provide curricula for digital information literacy; and technology, which can provide automated detection of harmful materials and help implement more ethically designed online choice architectures.

Although there is no silver bullet that could solve all the problems of the digital
world, Kozyreva and her colleagues describe three approaches to help mitigate the negative consequences. The first is to design Internet infrastructures that "nudge" people's behavior toward more positive outcomes, such as systems with default privacy-respecting settings. The second is relying more on "technocognition," which are technological solutions informed by psychological principles, such as creating obstacles to sharing offensive material online.

The final approach is improving people's cognitive and motivational competencies through "boosts," which are tactics that enhance people's agency in their digital environments and improve reasoning and resilience to manipulation. Examples of a boost include preventively inoculating users against most common manipulative practices and providing easy-to-use rules for digital literacy.

"These cognitive tools are designed to foster the civility of online discourse and protect reason and human autonomy against manipulative choice architectures, attention-grabbing techniques, and the spread of false information," said Kozyreva.

Credit: 
Association for Psychological Science

January issue of <i>SLAS Discovery</i> "Cryo-EM: The Resolution Revolution and Drug Discovery"

Oak Brook, IL - The January edition of SLAS Discovery features the cover article, "Cryo-EM: The Resolution Revolution and Drug Discovery" by Taiana Maia de Oliveira, Ph.D., Lotte van Beek, Ph.D., Fiona Shilliday, Ph.D., Judit E. Debreczeni, Ph.D., and Chris Phillips, Ph.D., from AstraZeneca.

Cryo-EM, a fast-growing technique in the pharmaceutical industry, enables structure determination of sought-after targets such as large multiprotein complexes and membrane proteins that eluded other structural biology methods. The intricate interactions between compounds and proteins are crucial in accelerating the drug discovery process. The cover article reviews how the structural understanding gained through Cryo-EM is influencing drug discovery projects focused on TRP channels, GPCRs, ribosomes and other high value targets.

The January issues of SLAS Discovery includes 13 articles of Original Research in addition to the cover article.

Articles of Original Research include:

In-Plate Cryopreservation of 2D and 3D Cell Models: Innovative Tools for Biomedical Research and Preclinical Drug Discovery

MALDI-TOF-Based Affinity Selection Mass Spectrometry for Automated Screening of Protein-Ligand Interactions at High-Throughput

High-Throughput Amenable MALDI-MS Detection of RNA and DNA with On-Surface Analyte Enrichment Using Fluorous Partitioning

Activity-Based Screening Assay for Mono-ADP-Ribosylhydrolases

Development of a Microscale Thermophoresis-Based Method for Screening and Characterizing Inhibitors of the Methyl-Lysine Reader Protein MRG15

Development of High-Throughput Assays for Evaluation of Hematopoietic Progenitor Kinase 1 Inhibitors

Development of a Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay for the Inhibition of Keap1-Nrf2 Protein-Protein Interaction

Identification of Small-Molecule Inhibitors of Neutral Ceramidase (nCDase) via Target-Based High-Throughput Screening

Optimization of a High-Throughput Cell-Based Screening Strategy to Identify Small Molecule Inhibitors of IL-23 Signaling

A New Method for Screening Natural Products to Stimulate IFN-γ Production in Jurkat Human T Lymphocytes

Validation of a High-Throughput Calcium Mobilization Assay for the Human Trace Amine-Associated Receptor 1

Development of a Testing Funnel for Identification of Small-Molecule Modulators Targeting Secretin Receptors

P-Glycoprotein-Mediated Efflux Using a Rapidly Maturing Caco2 Clone (CLEFF4) in Only 5 Days without Requiring Modified Growth Medium

Credit: 
SLAS (Society for Laboratory Automation and Screening)

Arthritis drug may treat immunotherapy-related heart complication

A drug typically prescribed for rheumatoid arthritis may also be effective in treating a rare but potentially deadly heart complication some cancer patients experience after taking immunotherapies, according to a study published in Cancer Discovery and co-led by investigators at Vanderbilt University Medical Center (VUMC).

The researchers demonstrated that the drug abatacept reduced the severity of myocarditis in a genetic mouse model study - responses that have also been observed in three human patients who were given the same drug after corticosteroid treatments failed to reduce heart muscle inflammation. The mouse model revealed the mechanisms for how the drug works.

Javid Moslehi, MD, director of Cardio-Oncology at Vanderbilt-Ingram Cancer Center, James Allison, PhD, executive director of the Immunotherapy Platform at MD Anderson Cancer Center, Spencer Wei, PhD, a former postdoctoral fellow at MD Anderson, and Justin Balko, PharmD, PhD, associate professor of Medicine and Pathology, Microbiology, and Immunology at VUMC and Vanderbilt-Ingram conceived the research project.

"Immune checkpoint inhibitors (ICI) have revolutionized cancer treatment but are associated with immune-related side effects, such as myocarditis, which although infrequent, has up to 50% mortality," said Moslehi, associate professor of Medicine, who is a corresponding author of the study along with Allison. "We have few treatment options for the fulminant cases of ICI-myocarditis."

Immune checkpoint inhibitors are immunotherapies that target CTLA-4 or PD-1/PD-L1, which are negative regulators of T-cell immune function. When these negative regulators are inhibited, increased activation of the immune system occurs. In some patients, the immune system overreacts, resulting in myocarditis or inflammation of the heart muscle. ICI-myocarditis was initially described by Moslehi, Balko and Doug Johnson, MD, MD, MSCI, associate professor of Medicine at Vanderbilt in 2016. The trio of Moslehi, Balko and Johnson then combined forces to better understand what was effectively a new clinical syndrome.

"As well as identifying a potential treatment, this work gives us a unique opportunity to understand why this syndrome occurs, how to identify patients at risk for it, and maybe even how to prevent it from occurring in the first place" said Balko.

By recreating ICI-myocarditis in the mouse, the group showed that CTLA-4 and PD-1 are both critical in the development of myocarditis. Additionally, reversing CTLA-4 signaling via abatacept stopped disease progression and reduced deaths in the mice model. Their work provides mechanistic rationale and support for therapeutic clinical studies.

Currently, corticosteroids are the standard of care for cancer patients who develop myocarditis after treatment with immune checkpoint inhibitors. Moslehi, Joe-Elie Salem, MD, PhD, a former post-doctoral research fellow at Vanderbilt and Johnson, along with researchers from Sorbonne University in Paris, previously reported a patient case in The New England Journal of Medicine, about a 66-year-old woman with lung cancer who recovered from a severe case of immunotherapy-related myocarditis after being treated with abatacept when she did not respond to corticosteroids. The researchers stated two other cancer patients benefited from treatment with abatacept after having no response to corticosteroids.

Credit: 
Vanderbilt University Medical Center

Beyond changing DNA itself, mutagens also cause errors in gene transcription

image: Assistant Professor Marc Vermulst

Image: 
USC/Stephanie Kleinman

Exposure to mutagens, or mutation-causing agents, can not only bring about changes in DNA but also appear to induce errors when genes are transcribed to make proteins, which may be an important factor in age-related diseases.

USC Leonard Davis School of Gerontology Assistant Professor Marc Vermulst and colleagues made the discovery by using state-of-the-art circle sequencing techniques to determine how frequently molecules called RNA polymerases make mistakes when they read (or "transcribe") our DNA. RNA polymerases transcribe DNA to make temporary copies of genes, which are then used to build all of the proteins required to keep us alive and healthy.

Transcription errors vastly outnumber DNA mutations

Vermulst compared our cells to a busy kitchen, teeming with hundreds of chefs that are all making dishes out of a single recipe book. Because it's so busy, they cannot take the recipe book with them when an order comes in. So instead they send the kitchen staff to the recipe book to read the recipes as carefully as possible and then bring the instructions to the chefs. Our cells work in a very similar manner. When an "order" for a protein comes in, RNA polymerases are sent to our genome (or in other words, our recipe book), to make a temporary copy of a gene. That temporary copy is then brought to the chefs, who cook the protein just like the message they received dictates. In this example, transcription errors could be an incorrect amount or ingredient that wasn't properly recorded by the person jotting down the recipe.

"The molecule doing the reading and writing is what's introducing the errors, even if the DNA itself isn't mutated," he explained.

To demonstrate that a mutagen - an agent that can cause a genetic mutation - can induce these errors, Vermulst and his team exposed yeast cells to the chemical N-Methyl-N?-nitro-N-nitrosoguanidine (MNNG), then screened for transcription errors. The cells exposed to MNNG displayed many more transcription errors than the unexposed cells, and in addition, the rate of transcription errors vastly outnumbered the rate of DNA mutations. The team confirmed similar results when the experiments were repeated in cells from the worm species C. elegans, fruit fly D. melanogaster and mice.

DNA mutations occur when the genome is inaccurately copied during cell division, leaving the newly formed cells with a mistake in their DNA. However, a few types of cells, including neurons and muscle cells, rarely divide in adults. These cells all still need to transcribe proteins, which means that harmful errors within these cells are much more likely to arise from transcription, Vermulst explained.

"There are a hundredfold more transcription errors being made for every DNA mutation that eventually arises," he said.

A possible role in several diseases

The genes that code for a protein not only instruct which amino acids to put in what order but also control the specific shape into which the finished protein folds itself. Transcription errors often cause proteins to misfold into a dysfunctional shape, which can result in clusters, or plaques, of nonfunctioning proteins that hinder healthy cell function. This raises questions of how these errors may play roles in diseases such as Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS) and others, Vermulst said.

In future research, Vermulst is pushing for more investigation into whether other substances known to cause DNA mutations also affect transcription, as well as if there are any substances previously thought of as safe that may be in fact inducing transcription errors.

"This is potentially a really important finding in the context of genetic toxicology: a new mechanism by which all these molecules - from exposures in our environment or from our lifestyle choices - can result in pathology," he said. "There could potentially be molecules that we're eating and drinking that are deemed safe because they don't result in any genetic changes, but do result in transcription errors, that have gone completely unnoticed because nobody had a tool to see whether or not that was happening."

He also hopes that the research will make new links between established pillars of aging research - DNA damage, mitochondrial dysfunction, oxidative species and others - and connect them in a mechanistic way to detrimental outcomes such as Alzheimer's, Parkinson's and cancer. It may also help identify sources of the symptoms in DNA repair deficiency disorder, in which patients are unable to repair damage to their genome properly and often results in accelerated aging or increased cancer risk.

While recent years have seen increased interest in the "transcriptome" - the entirety of what is transcribed from a genome - Vermulst wants to focus on the accuracy of what's being transcribed and not just the amount of each protein produced. He hopes this quality-over-quantity approach offers new insight into the fundamental processes of diseases.

"If you've done the same thing a hundred times and you don't get a solution for your problem, it might be something that you've overlooked," he said. "So we're trying to find this something else."

Credit: 
University of Southern California

Pneumolysis: High altitude specialists explain lung destruction caused by COVID-19

image: COVID-19 and pneumolysis simulating extreme high-altitude exposure with altered oxygen transport physiology.

Image: 
Dr. Gustavo R. Zubieta-Calleja and colleagues, Bentham Science Publishers

The current COVID-19 pandemic has caused over 1 million deaths which can be attributed to its severe progressive pulmonary compromise. The necessity to understand this disease has resulted in detailed analyses of its transmission and clinical aspects published worldwide. In this recent report, doctors in Bolivia provide, who live and work at more than 3,600m from above sea level, a high altitude specialists' perspective. At high-altitude, hypoxemia (low oxygen in the blood), the main complication in COVID-19, is every day's life experience at the High Altitude Pulmonary and Pathology Institute (HAPPI-IPPA) in La Paz, Bolivia, for 50+ years. Unlike high altitude illnesses, according to Prof. Dr. Gustavo Zubieta-Calleja, COVID-19 presents his transcendental new concept: "pneumolysis" (pneumo=lung, lysis=destruction).

View the video on the research: https://www.youtube.com/watch?v=fBaQMSF1QVo

Initially, all physicians worldwide assumed that the lung affliction in COVID-19 (evidenced by CAT scans and caused by SARS-CoV-2) was the same as in older strains SARS-CoV. However, as fatality rates increased in Intensive Care Units, it became evident that this pathology was entirely new.

The SARS-CoV-2 virus enters the body through inhalation of the viral load, and travels through the bronchi to the surface of the alveoli respiratory sacs where pneumocytes (alveolar lung cells), and their capillaries are located. The pneumocytes allow the diffusion of oxygen molecules to the capillaries where red blood cells capture and transport them to all tissues. They also allow the passage of carbon dioxide molecules (a waste product of respiration) to be exhaled.

SARS-CoV-2 penetrates pneumocytes through the ACE2 receptors and starts self-replication of its RNA within. Pneumocytes are eventually destroyed liberating all replicated SARS-CoV-2 RNA that further infect other adjacent pneumocytes. The paper authored by Prof. Dr. Gustavo Zubieta-Calleja, suggests that multiple diseases may arise from SARS-CoV-2 entering the capillaries.

The coronavirus intrusion gradually reduces the lung's gas exchange area. This results in alveoli inflammation and a superimposed alteration of lung function similar to High Altitude Pulmonary Edema (HAPE). Both in COVID-19 and HAPE, sea level patients cannot take in enough oxygen as if they were rapidly placed on the summit of Mt. Everest, without time for adaptation. Nevertheless, HAPE is entirely reversible as its mechanism is different, and there is no destruction of alveoli.

The extreme hypoxemia experienced in COVID-19 patients leads physicians to use ventilators (a mechanical way of pumping air into the lungs) to improve oxygenation. However, using high pressures on partially destroyed and fragile lungs can result in the worst outcomes. Whereas non-invasive ventilation results in better outcomes.

If patients survive the acute pneumolysis with critically low oxygen levels in COVID-19, recovery results in irreversible fibrosis (scars) in the lungs. This damaged tissue is no longer useful for gas exchange, so compensation can be commonly achieved by increasing the number of red blood cells (hemoglobin oxygen transporters). This poly-erythrocythemia) is a compensation mechanism found in high-altitude residents who suffer chronic lung diseases or other oxygen transport disorders, commonly known as "Chronic Mountain Sickness".

In COVID-19, sea level hemoglobin can also become insufficient. The authors postulate that a fundamental treatment strategy to increase the transport of oxygen could be erythropoietin. This hormone naturally increases red blood cell production and protects the heart, brain, and vessels from hypoxia's hazards.

Prompt administration of oxygen is important as it can reduce the formation of HAPE-type edema and cardiopulmonary overwork. The use of anti-inflammatory medication, being tops Aspirin for its analgesic, anti-inflammatory, anti-fever, and anti-coagulation effects, are also proposed. Timely use of antibiotics (to protect from super-infection), adequate oral rehydration, antitussives (promoting a resting lung) and other anti-coagulation drugs should also be considered on each individual case.

To allow people to return to work, Dr. Zubieta-Calleja proposes the use of space type earth suits with electric ventilator open circuit adequately filtered air, reducing contagion risk. The CoV-2 is a natural biological cleansing mechanism attacking more severely those with decreased immunity, inflammatory processes, or overlapping diseases. "The individual ultimate survival tool under COVID-19 presence..." as he explains: "is a strong immune system".

Credit: 
Bentham Science Publishers

Scientists discover a new type of brain cell that could help detect distance

image: Dr. Steven Poulter and Dr. Colin Lever in the lab discovering the cells.

Image: 
Dr. Steven Poulter and Dr. Colin Lever

The existence of GPS-like brain cells, which can store maps of the places we've been, like our kitchen or holiday destination, was already widely known, but this discovery shows there is also a type of brain cell sensitive to the distance and direction of objects that can store their locations on these maps.

The research, led by Dr Steven Poulter and Dr Colin Lever from Durham University, and co-directed by Dr Thomas Wills from the University of Central London (UCL), found that Vector Trace cells can track how far we have travelled and remember where things are, which are added to our memory map of the places we have been.

Dr Steven Poulter said: "The discovery of Vector Trace cells is particularly important as the area of the brain they are found in is one of the first to be attacked by brain disorders such as Alzheimer's disease, which could explain why a common symptom and key early 'warning sign' is the losing or misplacement of objects."

Dr Lever added: "It looks like Vector Trace cells connect to creative brain networks which help us to plan our actions and imagine complex scenarios in our mind's eye. Vector trace cells acting together likely allow us to recreate the spatial relationships between ourselves and objects, and between the objects in a scene, even when those objects are not directly visible to us."

Brain cells that make up the biological equivalent of a satellite-navigation system were first discovered > by Professors John O'Keefe, Edvard Moser, May-Britt Moser. Their discovery shed light on one of neurosciences great mysteries - how we know where we are in space - and won them the 2014 Nobel Prize in Medicine.

Speaking about the discovery, Professor John O'Keefe said: "I'm very impressed. Not only have they discovered a new type of brain cell, the Vector Trace cell, but their analysis of its properties is exhaustive and compelling. This discovery sheds considerable light on this important but enigmatic structure of the brain, supporting the idea that it is indeed the memory system we have always believed it to be."

Professor Lord Robert Winston added: "This fascinating work on Vector Trace cells uncovers further levels of our memory, so often lost with brain damage and ageing. This discovery gives a possible insight into certain kinds of dementia which are now of massive importance.

He added: "The idea that loss or change of such cells might be an early biomarker of disease could lead to earlier diagnosis and more effective therapies for one of the most intractable medical conditions."

Credit: 
Durham University

Consumers challenged by high status peers make a 'status pivot,' new study finds

Chestnut Hill, Mass. (12/21/2020) - When confronted with comparisons to high status friends and colleagues, consumers prefer to make a "status pivot" into another area where they can shine brighter than their successful peers, according to new research into how consumers respond to status competition, which appears in the Journal of Consumer Research.

With a status pivot, consumers "change the game" when they buy and display products to showcase their accomplishments in other areas where they fare better, referred to as "alternative domains," than if they try to hold firm and buy products in the domain where their peers prevail, said Boston College Associate Professor of Marketing Nailya Ordabayeva, a co-author of the new paper.

On the one hand, when faced with a peer who displays the trappings of financial success and professional achievements, a consumer could entrench and purchase goods and services in the same area as the peer in an effort to reflect equal levels of success. Instead, the new research shows, individuals prefer to make a status pivot and excel in alternative domains - such as personal relationships, social life, parenting, physical and mental health, and fitness.

The findings hold implications for marketers of premium and luxury brands who are trying to understand what kind of products consumers embrace to compete with others, and what kinds of products can help relieve consumers' stress about "upward comparison," according to Ordabayeva.

"We examined how people choose among different product options and consumption strategies to cope with such status threats and how effective these strategies are in alleviating the stress of upward comparisons," said Ordabayeva. "We show that comparison to more successful peers strengthens consumers' belief that success in one life domain, such as financial well-being, must come at the cost of failure in other life domains, such as personal life, which ultimately boosts consumers' preference to display success in these alternative domains where they believe their successful peers may be failing."

The researchers examined consumption choices in a variety of settings: runners at the Boston Marathon, golfers in Switzerland, residents and visitors to glamorous Monaco, users of a social media platform, working parents, as well as hundreds of survey takers online. They looked for the ways in which consumers choose their status coping strategies - staying within domain, or pivoting to another area, an alternative domain.

In a number of the team's studies, the researchers examined consumers' choices in the form of which bumper sticker they would display on their car. When being compared to financially more successful peers, Boston Marathon runners, survey takers online, and owners of inexpensive cars at an elite Swiss golf club showed interest in displaying car bumper stickers that showcased their accomplishments in alternative domains such as family, spirituality, and volunteering.

In addition, being compared to successful peers led consumers to display pictures and messages about family, parenthood, and friendships, rather than professional accomplishments, on their coffee mugs and smartphone covers, according to Ordabayeva and co-authors Dafna Goor, of London Business School, and Anat Keinan, of Boston University.

"We found that pivoting to alternative domains is so appealing and effective because experiencing a status threat motivates consumers to focus on trade-offs and downsides associated with achieving high status," said Ordabayeva. "Importantly, we find that status pivoting is particularly prevalent when consumers do not believe they can attain a similar level of success in the domain of the threat as their successful peer."

Ordabayeva said the researchers were surprised to see how much more appealing status pivoting is for a broad range of consumer groups when compared to choosing to pursue status restoration within the same domain as a successful peer. Unlike previous studies that focused on within-domain status restoration, the project offered study participants an alternative strategy to consider.

"The fact that simply giving people more options to cope with status threats can so dramatically shift their preferences away from within-domain restoration and toward status pivoting was surprising to us, and it highlighted that we have still much to learn about tactics that can increase consumers' resilience against status threats in the marketplace," Ordabayeva said.

She said the findings point to the need for further study of status pivoting, including how particular demographic groups embrace the strategy and whether or not seeking high status recognition in another aspect of life motivates consumers to put more time and effort into alternate domains like parenting, or personal relationships.

Credit: 
Boston College